FDA Says “New Regulatory Pathway is Needed” for CBD Regulation

The seemingly natural appointee to regulate CBD products, the U.S. Food and Drug Administration, has announced that it doesn’t have the authority to take on that task. FDA principal deputy commissioner, Janet Woodcock, detailed the decision in a statement yesterday, explaining that: After “careful review,” the federal agency has concluded that existing regulatory frameworks for food and supplements are not fit for CBD, and “a new regulatory pathway is needed” for the compound – one that “balances individuals’ desire for